Concerns & Risks -- 7/10
| Metric | FY2026E | Multiple | Peer |
|---|---|---|---|
| P/E (FY26E) | EPS $151.39 | ~20.7x | ORLY ~31x |
| P/E (FY27E) | EPS $175.62 | ~17.8x | -- |
| ~33% P/E discount to closest comp ORLY despite comparable returns and faster-improving top line. | |||
| Catalyst | Detail | Character |
|---|---|---|
| Mega-hub rollout | 156 today, ~15 more Q4 FY26, 40+ FY27. Driving commercial lift. | Near-term, compounding |
| Commercial/DIFM share gains | Only ~5% of $130B market. +10.4% growth. Long runway. | Structural |
| Weather/seasonal snapback | Q3 softness was weather; A/C and starting rebound expected Q4. | Near-term |
| Accelerated store growth | ~365 FY26 vs 305 FY25. Comp waterfall tailwind. | Near-term |
| International rebound | Mexico/Brazil soft; reaccelerate on macro recovery. | Medium-term |
| Buyback | ~2% share reduction/quarter ($586M Q3 FY26). EPS growth re-accelerates +16% FY27E. | Ongoing, mechanical |
| Risk | Detail |
|---|---|
| Congressional China-supplier scrutiny | Select Committee warned AZO re: Chinese imports evading tariffs. Reputational + compliance risk. |
| Tariff policy | Ongoing reciprocal/auto-parts/steel tariffs. Offset via pricing but DIY demand elasticity is the swing. |
| Antitrust / franchise | No antitrust or franchise-model threats. |
Score of 7/10 reflects a clear valuation tailwind (33% discount to ORLY), zero China demand exposure, and a dense near-term catalyst slate anchored by mega-hub rollout and commercial share gains. The aging vehicle fleet (12.8+ years) provides durable secular demand support, while the buyback engine mechanically compounds EPS.
Why not higher (8-10): China sourcing exposure is significant (~45% of total imports) and draws active Congressional scrutiny -- a reputational and compliance tail risk that is difficult to model. Tariffs drove FY26 same-SKU inflation >7% and LIFO charges of $207M vs $64M FY25, compressing gross margins. DIY traffic is persistently negative (-3.6%), meaning growth is price-driven, not volume-driven. The ~20.7x forward multiple sits above AZO's own 18.9x historical median.
Why not lower (5-6): The P/E discount to ORLY is too wide for the quality gap. Revenue is accelerating (+8.4%). Mega-hub maturation, commercial DIFM share gains (only ~5% of a $130B market), and buyback-driven EPS compounding (+16% FY27E) are concrete, near-term, and credible. No antitrust, franchise-model, or China demand-side threats exist. Weather-related Q3 softness has a clear snapback catalyst in Q4.
Net assessment: AZO is a high-quality compounder with a meaningfully discounted multiple and visible catalysts, held back from a top-tier score by real China-sourcing risk, tariff-driven margin compression, and Congressional scrutiny that adds a layer of uncertainty absent from peers.